Correlation Between TTY Biopharm and Synmosa Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TTY Biopharm and Synmosa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TTY Biopharm and Synmosa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TTY Biopharm Co and Synmosa Biopharma, you can compare the effects of market volatilities on TTY Biopharm and Synmosa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TTY Biopharm with a short position of Synmosa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of TTY Biopharm and Synmosa Biopharma.

Diversification Opportunities for TTY Biopharm and Synmosa Biopharma

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between TTY and Synmosa is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding TTY Biopharm Co and Synmosa Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synmosa Biopharma and TTY Biopharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TTY Biopharm Co are associated (or correlated) with Synmosa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synmosa Biopharma has no effect on the direction of TTY Biopharm i.e., TTY Biopharm and Synmosa Biopharma go up and down completely randomly.

Pair Corralation between TTY Biopharm and Synmosa Biopharma

Assuming the 90 days trading horizon TTY Biopharm Co is expected to generate 0.65 times more return on investment than Synmosa Biopharma. However, TTY Biopharm Co is 1.54 times less risky than Synmosa Biopharma. It trades about 0.02 of its potential returns per unit of risk. Synmosa Biopharma is currently generating about 0.0 per unit of risk. If you would invest  7,680  in TTY Biopharm Co on November 28, 2024 and sell it today you would earn a total of  10.00  from holding TTY Biopharm Co or generate 0.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

TTY Biopharm Co  vs.  Synmosa Biopharma

 Performance 
       Timeline  
TTY Biopharm 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in TTY Biopharm Co are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, TTY Biopharm is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Synmosa Biopharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Synmosa Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Synmosa Biopharma is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

TTY Biopharm and Synmosa Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TTY Biopharm and Synmosa Biopharma

The main advantage of trading using opposite TTY Biopharm and Synmosa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TTY Biopharm position performs unexpectedly, Synmosa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synmosa Biopharma will offset losses from the drop in Synmosa Biopharma's long position.
The idea behind TTY Biopharm Co and Synmosa Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges